Free and glucuronide whole blood cannabinoids' pharmacokinetics after controlled smoked, vaporized, and oral cannabis administration in frequent and occasional cannabis users … MN Newmeyer, MJ Swortwood, AJ Barnes, OA Abulseoud, ... Clinical chemistry 62 (12), 1579-1592, 2016 | 183 | 2016 |
Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis MJ Swortwood, DM Boland, AP DeCaprio Analytical and Bioanalytical Chemistry 405, 1383-1397, 2013 | 106 | 2013 |
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration MJ Swortwood, MN Newmeyer, M Andersson, OA Abulseoud, ... Drug testing and analysis 9 (6), 905-915, 2017 | 100 | 2017 |
Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis … MN Newmeyer, MJ Swortwood, OA Abulseoud, MA Huestis Drug and alcohol dependence 175, 67-76, 2017 | 88 | 2017 |
Cross‐reactivity of designer drugs, including cathinone derivatives, in commercial enzyme‐linked immunosorbent assays MJ Swortwood, WL Hearn, AP DeCaprio Drug Testing and Analysis 6 (7-8), 716-727, 2014 | 87 | 2014 |
Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ9-Tetrahydrocannabinol in … MN Newmeyer, MJ Swortwood, M Andersson, OA Abulseoud, ... Clinical chemistry 63 (3), 647-662, 2017 | 59 | 2017 |
4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry KN Ellefsen, A Wohlfarth, MJ Swortwood, X Diao, M Concheiro, ... Forensic toxicology 34, 61-75, 2016 | 58 | 2016 |
Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance EL Karschner, MJ Swortwood, J Hirvonen, RS Goodwin, WM Bosker, ... Drug testing and analysis 8 (7), 682-689, 2016 | 57 | 2016 |
Identifying and Quantifying Cannabinoids in Biological Matrices in the Medical and Legal Cannabis Era EL Karschner, MJ Swortwood-Gates, MA Huestis Clinical Chemistry 66 (7), 888-914, 2020 | 56 | 2020 |
In Vitro, in Vivo and In Silico Metabolic Profiling of α-Pyrrolidinopentiothiophenone, A Novel Thiophene Stimulant MJ Swortwood, J Carlier, KN Ellefsen, A Wohlfarth, X Diao, ... Bioanalysis 8 (1), 65-82, 2016 | 56 | 2016 |
5F‐MDMB‐PICA metabolite identification and cannabinoid receptor activity MT Truver, S Watanabe, A Åstrand, S Vikingsson, H Green, ... Drug Testing and Analysis 12 (1), 127-135, 2020 | 54 | 2020 |
Quantification of Morphine, Codeine, and Thebaine in Home‐Brewed Poppy Seed Tea by LC‐MS/MS D Powers, S Erickson, MJ Swortwood Journal of Forensic Sciences 63 (4), 1229-1235, 2018 | 54 | 2018 |
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration MN Newmeyer, MJ Swortwood, ME Taylor, OA Abulseoud, TH Woodward, ... Journal of applied toxicology 37 (8), 922-932, 2017 | 47 | 2017 |
Maternal buprenorphine maintenance and lactation LM Jansson, N Spencer, K McConnell, M Velez, M Tuten, CA Harrow, ... Journal of Human Lactation 32 (4), 675-681, 2016 | 46 | 2016 |
Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS KB Palmquist, MJ Swortwood Forensic science international 297, 189-197, 2019 | 43 | 2019 |
First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry MJ Swortwood, KN Ellefsen, A Wohlfarth, X Diao, M Concheiro-Guisan, ... Analytical and bioanalytical chemistry 408, 4845-4856, 2016 | 43 | 2016 |
Long‐term stability of cannabinoids in oral fluid after controlled cannabis administration KB Scheidweiler, M Andersson, MJ Swortwood, C Sempio, MA Huestis Drug Testing and Analysis 9 (1), 143-147, 2017 | 34 | 2017 |
Quantitative analysis of novel synthetic opioids, morphine and buprenorphine in oral fluid by LC–MS-MS MT Truver, MJ Swortwood Journal of Analytical Toxicology 42 (8), 554-561, 2018 | 29 | 2018 |
Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography–tandem mass spectrometry MJ Swortwood, KB Scheidweiler, AJ Barnes, LM Jansson, MA Huestis Journal of chromatography A 1446, 70-77, 2016 | 25 | 2016 |
Quantification of U-47700 and its metabolites in plasma by LC-MS/MS CR Smith, MT Truver, MJ Swortwood Journal of Chromatography B 1112, 41-47, 2019 | 21 | 2019 |